Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update

Hematopoietic cell transplant (HCT) can cure both children and adults with sickle cell disease. Outcomes have historically been poor for the vast majority of patients who lack a matched sibling donor. However, the development of haploidentical HCT (haplo-HCT) with high doses of posttransplant cyclop...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Dilan A. Patel, Adeseye M. Akinsete, Josu de la Fuente, Adetola A. Kassim
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wolters Kluwer Medknow Publications 2020-04-01
Ráidu:	Hematology/Oncology and Stem Cell Therapy
Fáttát:	cyclophosphamide haploidentical transplant sickle cell disease thiotepa total body irradiation
Liŋkkat:	https://journals.lww.com/10.1016/j.hemonc.2020.01.002
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!